Table 2.
Relationship between EphA7 expression or microvessel count and clinicopathological features of 32 patients with GBM.
| EphA7 expression | P value | MVD | P value | |||
| Age | N | positive (%) | N | high MVD N (%) | ||
| <= 50 | 10 | 3 (30) | 11 | 6 (54.55) | ||
| >50 | 22 | 19 (86.36) | 0.003 | 21 | 16 (76.19) | ns |
| Gender | ||||||
| male | 21 | 15 (71.43) | 21 | 15 (71.43) | ||
| female | 11 | 7 (63.64) | ns | 11 | 8 (72.72) | ns |
| Tumor status | ||||||
| Primary | 26 | 20 (76.92) | 26 | 22 (84.62) | ||
| Recurrence | 6 | 2 (33.33) | ns | 6 | 1 (16.67) | 0.003 |
MVD: microvessel density, N: number of patients, ns: not significant. The median MVD of 30 vessels was used as a cutpoint.